share_log

汇宇制药(688553.SH):克拉屈滨注射液、注射用盐酸罗沙替丁醋酸酯获得药品注册证书

Huiyu Pharmaceutical (688553.SH): Cladribine injections, roxatidine hydrochloride acetate for injections obtained drug registration certificates

Gelonghui Finance ·  May 14 04:16

Gelonghui, May 14 | Huiyu Pharmaceutical (688553.SH) announced that it has recently received the “Drug Registration Certificate” approved and issued by the State Drug Administration. Drug name: cladribine injection, roxatidine hydrochloride acetate for injection. Cladribine is a synthetic antineoplastic drug. Rosatidine is a histamine H2 receptor antagonist.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment